Abstract
Priapism is defined as a genuine erectile disorder, in which erection persists uncontrollably without sexual purpose. This disorder is often overlooked in comparison to other male sexual dysfunctions, principally because of its seeming rarity. Priapism, however, occurs frequently in certain patient populations, including those with hematologic dyscrasias. Most commonly, priapism affects patients with sickle cell disease. The reported prevalence rate in this group ranges between 29% and 42% of males. The significance of priapism is further emphasized by the fact that this disorder commonly causes erectile tissue damage and leads to the loss of functional erections. These observations highlight the need for proper clinical recognition of priapism in order to enable appropriate management. Here, the current knowledge of priapism as it relates to hematologic and coagulative diseases is discussed, with a focus on the diagnosis and treatment of the disorder.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Berger R et al. (2001) Report of the American Foundation for Urologic Disease (AFUD) thought leader panel for evaluation and treatment of priapism. Int J Impot Res 13 (Suppl 5): S39–S43
Montague DK et al. (2003) American Urological Association guideline on the management of priapism. J Urol 170: 1318–1324
Emond AM et al. (1980) Priapism and impotence in homozygous sickle cell disease. Arch Intern Med 140: 1434–1437
Fowler JE Jr et al. (1991) Priapism associated with the sickle cell hemoglobinopathies: prevalence, natural history and sequelae. J Urol 145: 65–68
Mantadakis E et al. (1999) Prevalence of priapism in children and adolescents with sickle cell anemia. J Pediatr Hematol Oncol 21: 518–522
Adeyoju AB et al. (2002) Priapism in sickle-cell disease; incidence, risk factors and complications— an international multicentre study. BJU Int 90: 898–902
Nelson JH and Winter CC (1977) Priapism: evolution of management in 48 patients in a 22-year series. J Urol 117: 455–458
Miller ST et al. (1995) Priapism in children with sickle cell disease. J Urol 154: 844–847
Thuret I et al. (1996) Priapism following splenectomy in an unstable hemoglobin: hemoglobin Olmsted β141 (H19) Leu→Arg. Am J Hematol 51: 133–136
Quigley M and Fawcett DP (1999) Thrombophilia and priapism. BJU Int 83: 155
Schreibman SM et al. (1974) Management of priapism in patients with chronic granulocytic leukemia. J Urol 111: 786–788
Steinhardt GF and Steinhardt E (1981) Priapism in children with leukemia. Urology 18: 604–606
Morano SG et al. (2000) Treatment of long-lasting priapism in chronic myeloid leukemia at onset. Ann Hematol 79: 644–645
Atala A et al. (1992) Priapism associated with asplenic state. Urology 40: 371–373
Brown JA and Nehra A (1998) Erythropoietin-induced recurrent veno-occlusive priapism associated and end-stage renal disease. Urology 52: 328–330
Fassbinder W et al. (1976) Factors predisposing to priapism in haemodialysis patients. Proc Eur Dial Transplant Assoc 12: 380–386
Routledge PA et al. (1998) Case studies in therapeutics: warfarin resistance and inefficacy in a man with recurrent thromboembolism, and anticoagulant-associated priapism. Br J Clin Pharmacol 46: 343–346
Bschleipfer TH et al. (2001) Heparin-induced priapism. Int J Impot Res 13: 357–359
Klein LA et al. (1972) Surgical treatment of priapism: with a note on heparin-induced priapism. J Urol 108: 104–106
Hebuterne X et al. (1992) Priapism in a patient treated with total parenteral nutrition. JPEN J Parenter Enteral Nutr 16: 171–174
Foda MM et al. (1996) High-flow priapism associated with Fabry's disease in a child: a case report and review of the literature. Urology 48: 949–952
Hinman F Jr (1960) Priapism; reasons for failure of therapy. J Urol 83: 420–428
Pryor J et al. (2004) Priapism, peyronie's disease, penile reconstructive surgery. In Sexual Medicine Sexual Dysfunctions in Men and Women, 383–408 (Eds Lue TF et al.) Paris: Health Publications
Serjeant GR et al. (1985) Stilboestrol and stuttering priapism in homozygous sickle-cell disease. Lancet 2: 1274–1276
Tarry WF et al. (1987) Urological complications of sickle cell disease in a pediatric population. J Urol 138: 592–594
Datta NS (1977) Megalophallus in sickle cell disease. J Urol 117: 672–673
Ramos CE et al. (1995) High flow priapism associated with sickle cell disease. J Urol 153: 1619–1621
Lue TF et al. (1986) Priapism: a refined approach to diagnosis and treatment. J Urol 136: 104–108
Hakim LS et al. (1996) Evolving concepts in the diagnosis and treatment of arterial high flow priapism. J Urol 155: 541–548
Seftel AD et al. (1998) High flow priapism complicating veno-occlusive priapism: pathophysiology of recurrent idiopathic priapism? J Urol 159: 1300–1301
Pond HS (1969) Priapism as the presenting complaint of myelogenous leukemia: case report and review of the physiology of erection and the pathophysiology and treatment of priapism. South Med J 62: 465–467
Larocque MA and Cosgrove MD (1974) Priapism: a review of 46 cases. J Urol 112: 770–773
Winter CC and McDowell G (1988) Experience with 105 patients with priapism: update review of all aspects. J Urol 140: 980–983
Pohl J et al. (1986) Priapism: a three-phase concept of management according to aetiology and prognosis. Br J Urol 58: 113–118
Levine JF et al. (1991) Recurrent prolonged erections and priapism as a sequela of priapism: pathophysiology and management. J Urol 145: 764–767
Hinman F (1914) Priapism. Ann Surg 60: 689–716
Melman A and Serels S (2000) Priapism. Int J Impot Res 12 (Suppl 4): S133–S139
Burnett AL (2003) Priapism pathophysiology: clues to prevention. Int J Impot Res 15 (Suppl 5): S80–S85
Lin G et al. (2003) Up and down-regulation of phosphodiesterase-5 as related to tachyphylaxis and priapism. J Urol 170 (Suppl): S15–S19
Champion HC et al. (2005) Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism. Proc Natl Acad Sci USA 102: 1661–1666
Feldstein VA (1993) Posttraumatic “high flow” priapism: evaluation with color flow doppler sonography. J Ultrasound Med 12: 589–593
Chung SY et al. (2003) Novel technique in the management of low flow priapism. J Urol 170: 1952
Mantadakis E et al. (2000) Outpatient penile aspiration and epinephrine irrigation for young patients with sickle cell anemia and prolonged priapism. Blood 95: 78–82
Monga M et al. (1996) Priapism in sickle cell disease: the case for early implantation of the penile prosthesis. Eur Urol 30: 54–59
Rees RW et al. (2002) The management of low-flow priapism with the immediate insertion of a penile prosthesis. BJU Int 90: 893–897
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Burnett, A. Therapy insight: priapism associated with hematologic dyscrasias. Nat Rev Urol 2, 449–456 (2005). https://doi.org/10.1038/ncpuro0277
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpuro0277